BSEM

BioStem Technologies, Inc. (BSEM) Risks & Opportunities Analysis (2026)

Invetso Score: 8/10 — Strong · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Risks

Score: 7.8 (Strong)

Low leverage and modest net debt reduce refinancing pressure versus more levered peers, limiting balance-sheet risk even if operating conditions soften.

Current and quick ratios below 1.0 indicate tighter near-term liquidity than stronger peers, which could constrain working-capital flexibility in a demand slowdown.

A very long cash conversion cycle driven by high inventory and payables days can amplify execution risk versus faster-turning peers if demand normalizes unevenly.

Zero reported interest coverage likely reflects data limitations or weak earnings visibility, but it still signals less transparent debt-service capacity than peers with clearer coverage metrics.

Opportunities

Score:

Very low net debt-to-EBITDA gives BSEM more financial flexibility than leveraged peers, supporting capacity to absorb volatility and fund growth if demand improves.

Negative days sales outstanding and a deeply negative cash conversion cycle indicate strong working-capital extraction versus peers, which can support cash generation and resilience.

Low debt-to-equity relative to peers reduces balance-sheet drag, improving positioning if the company can sustain operations through cyclical or pricing pressure.

If inventory turns improve from elevated days inventory outstanding, BSEM could convert operational efficiency into stronger free-cash-flow visibility versus slower-turning peers.

Overall Score

Score:

BSEM’s low leverage and strong working-capital dynamics support a favorable forward position versus peers, while sub-1.0 liquidity and inventory-heavy execution risks temper the upside.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on BioStem Technologies, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →